Rachit Khandelwal, Pediatrics BMT fellow at Medanta The Medicity, shared on X:
Title: Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study
Authors: Lei Ju, Sifeng Gao, JiLei Zhang, Yuyu Liu, Qiang Song, Lin Dong, Yan Guo, Xuemei Qin, Jie Zou, Chenglu Yuan, Yan Shi, Dexiao Kong, Kaifeng Wang, Qiang Li, Donglin Yang, Qingliang Teng, Erlie Jiang, Jun Peng, Guanchen Ba
Read The Full Article.
